Related Experiment Video
Updated: Jul 6, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling
Madesh Belakavadi1, Pradeep K Pandey, Ravi Vijayvargia
1Department of Physiology and Biophysics, Robert Wood Johnson Medical School, UMDNJ, Piscataway, NJ 08854, USA.
Abstract:
Mediator is a conserved multisubunit complex that acts as a functional interface between regulatory transcription factors and the general RNA polymerase II initiation apparatus. MED1 is a pivotal component of the complex that binds to nuclear receptors and a broad array of other gene-specific activators. Paradoxically, MED1 is found in only a fraction of the total cellular Mediator complexes, and the mechanisms regulating its binding to the core complex remain unclear. Here, we report that phosphorylation of MED1 by mitogen-activated protein kinase-extracellular signal-regulated kinase (MAPK-ERK) promotes its association with Mediator. We show that MED1 directly binds to the MED7 subunit and that ERK phosphorylation of MED1 enhances this interaction. Interestingly, we found that both thyroid and steroid hormones stimulate MED1 phosphorylation in vivo and that MED1 phosphorylation is required for its nuclear hormone receptor coactivator activity. Finally, we show that MED1 phosphorylation by ERK enhances thyroid hormone receptor-dependent transcription in vitro. Our findings suggest that ERK phosphorylation of MED1 is a regulatory mechanism that promotes MED1 association with Mediator and, as such, may facilitate a novel feed-forward action of nuclear hormones.
Insights
Mitogen-activated protein kinase-extracellular signal-regulated kinase (MAPK-ERK) phosphorylation enhances MED1 binding to the Mediator complex. This phosphorylation is stimulated by hormones and is crucial for nuclear hormone receptor coactivator activity and transcription.
Area of Science:
- Molecular Biology
- Gene Regulation
- Cell Signaling
Background:
- Mediator is a crucial transcriptional co-activator complex.
- MED1 is a key subunit that interacts with transcription factors.
- Mechanisms controlling MED1's association with Mediator are largely unknown.
Purpose of the Study:
- To investigate the role of MED1 phosphorylation in its association with the Mediator complex.
- To elucidate the signaling pathways regulating MED1's function.
- To understand the impact of MED1 phosphorylation on nuclear hormone receptor activity.
Main Methods:
- In vitro kinase assays using MAPK-ERK and MED1.
- Co-immunoprecipitation assays to assess protein interactions.
- Reporter gene assays to measure transcriptional activity.
Main Results:
- MAPK-ERK directly phosphorylates MED1.
- Phosphorylation enhances the binding of MED1 to the MED7 subunit of Mediator.
- Thyroid and steroid hormones stimulate MED1 phosphorylation in cells.
- MED1 phosphorylation is essential for its coactivator function with nuclear hormone receptors.
- ERK-mediated phosphorylation of MED1 boosts thyroid hormone receptor-dependent transcription.
Conclusions:
- ERK phosphorylation of MED1 is a regulatory mechanism controlling its association with the Mediator complex.
- This pathway links extracellular signals (hormones) to transcriptional regulation via MED1.
- Phosphorylated MED1 may play a role in a novel feed-forward loop for nuclear hormone signaling.
Related Concept Videos
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators
MAPK Signaling Cascades
Regulation of Nuclear Protein Sorting
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

